| Literature DB >> 30360570 |
Marco Iannaccone1, Ramy Elgendy2,3, Mery Giantin4, Camillo Martino5, Daniele Giansante6, Andrea Ianni7, Mauro Dacasto8, Giuseppe Martino9.
Abstract
Grape pomace (GPO), the main by-product of the wine making process, is a rich source of polyphenols with potent antioxidant properties. Recently, GPO has emerged as a potential feed additive in livestock nutrition, with several reports describing its beneficial effects on animals' overall health status or production traits. However, little is known about it from a molecular biology standpoint. In the present study, we report the first RNA sequencing-based whole-transcriptome profiling of Friesian calves fed with a GPO-supplemented diet. We identified 367 differentially expressed genes (p < 0.05) in the GPO-supplemented calves (n = 5), when compared with unsupplemented control group (n = 5). The pathway analysis showed that 'cholesterol lipid biosynthesis' was the most negatively-enriched (p < 0.001) pathway in the GPO-supplemented animals. In specific terms, five important genes coding for cholesterol biosynthesis enzymes, namely the Farnesyl-diphosphate Farnesyltransferase 1 (FDFT-1), Squalene Epoxidase (SQLE), NAD(P)-dependent Steroid Dehydrogenase-like (NSDHL), Methylsterol Monooxygenase (MSMO)-1, and Sterol-C5-desaturase (SC5D), two major transcription factors (the Sterol Regulatory Element-binding Transcription Factor 1 and 2), as well as the Low-Density Lipoprotein Receptor (LDLR), were all downregulated following GPO supplementation. Such an effect was mirrored by a reduction of blood cholesterol levels (p = 0.07) and a lowered (p < 0.001) Malondialdehyde (lipid oxidation marker) level in carcasses. We provide evidence on the effects of GPO-supplemented diets on the whole-transcriptome signature in veal calves, which mainly reflects an antioxidant activity.Entities:
Keywords: RNA-seq; blood; cattle; cholesterol biosynthesis; grape pomace; transcriptomics
Year: 2018 PMID: 30360570 PMCID: PMC6262483 DOI: 10.3390/ani8110188
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Chemical composition of the alfalfa diet composition.
| Parameters | % |
|---|---|
| Dry matter | 87.13 |
| Crude protein | 16.35 |
| Ash | 9.47 |
| Ether extract | 1.21 |
| Neutral detergent fiber | 30.75 |
| Acid detergent fiber | 21.43 |
| Acid detergent lignin | 6.78 |
Ingredients and chemical composition of the custom-formulated diet.
| Ingredient | Composition % | |
|---|---|---|
| Control Group | Grape Pomace Group | |
| Corn | 22 | 34 |
| Grain dust | 14 | 22 |
| Grape pomace flour | 0 | 10 |
| Fine bran | 9.6 | 3.4 |
| Sunflower seed | 10 | 4.4 |
| Faba bean | 7.5 | 0 |
| Biscuits waste | 5.3 | 6.4 |
| Distillers mais | 5 | 1 |
| Corn gluten feed | - | 9 |
| Barley | 8.2 | 4 |
| Bran wheat | 5 | 0 |
| Orange pulp dried | 3.7 | 0 |
| Soybean meal | 2.9 | 0 |
| Calcium carbonate | 25 | 1.6 |
| Molasses | 1 | 1 |
| Soybean hull | 0.6 | 0 |
| Common salt | 0.6 | 0.6 |
| Sodium bicarbonate 27% | 0.5 | 0.8 |
| Soybean oil | 0.4 | |
| Dicalcium phosphate | 0 | 0.6 |
| Magnesium oxide | 0.4 | 0.4 |
| Vitamin Premix | 0.8 | 0.8 |
|
| ||
| Dry matter | 88.5 | 88.6 |
| Crude protein | 16.0 | 15.91 |
| Ash | 7.5 | 7.53 |
| Ether extract | 3.75 | 4.0 |
| Crude Fiber | 7.65 | 7.24 |
| Starch | 31.0 | 33.5 |
| Neutral detergent fiber | 20.37 | 18.90 |
| Acid detergent fiber | 7.95 | 8.32 |
| Acid detergent lignin | 3.50 | 3.86 |
Figure 1Effect of grape pomace (GPO)-supplemented diet on blood cell counts. Each point represents a single subject, and data are expressed as percentage. Any possible differences were analyzed by using the Student’s t-test. CTR: a control group.
Figure 2Effect of GPO-supplemented diet on selected plasma parameters. Each point represents a single subject, and possible differences were analyzed by using the Student’s t-test.
Figure 3Principal component analysis (PCA) plot of the differentially expressed genes (DEGs) in veal calves after 75-days of grape pomace (GPO) supplementation, compared with unsupplemented control group (CTR). The GPO-supplemented animals (orange circles, right side) are separated from the unsupplemented CTR animals (green circles, left side) with the first two components (PCA1 and PCA2) accounting for 69% of the total variation. The PCA plots were created using the Clustvis tool (https://biit.cs.ut.ee/clustvis/) by [21]. For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.
Pathways represented among the DEG in GPO vs. CTR (Ingenuity Pathway (IPA) analysis).
| Canonical Pathways | -Log ( | Ratio | Molecules |
|---|---|---|---|
| Cholesterol Biosynthesis I | 5.76 | 0.385 | FDFT1,SQLE,NSDHL,MSMO1,SC5D |
| Cholesterol Biosynthesis II (via 24,25-dihydrolanosterol) | 5.76 | 0.385 | FDFT1,SQLE,NSDHL,MSMO1,SC5D |
| Cholesterol Biosynthesis III (via Desmosterol) | 5.76 | 0.385 | FDFT1,SQLE,NSDHL,MSMO1,SC5D |
| Superpathway of Cholesterol Biosynthesis | 5.25 | 0.222 | FDFT1,SQLE,NSDHL,IDI1,MSMO1,SC5D |
| Epoxysqualene Biosynthesis | 3.53 | 1 | FDFT1,SQLE |
| Zymosterol Biosynthesis | 2.37 | 0.333 | NSDHL,MSMO1 |
| IL-1 Signaling | 2.33 | 0.0667 | GNAI3,IL1A,PRKAR2B,MAPK8,GNA13,IRAK4 |
| PPAR Signaling | 2.26 | 0.0645 | SRA1,IL1A,PDGFA,IL1RL1,PDGFRA,PTGS2 |
| Toll-like Receptor Signaling | 2.09 | 0.0694 | UBD,IL1A,IL1RL1,MAPK8,IRAK4 |
| Role of JAK family kinases in IL-6-type Cytokine Signaling | 2.05 | 0.12 | SOCS1,MAPK8,OSM |
| NF-κB Signaling | 1.97 | 0.0462 | IL1A,BCL10,MAPK8,FCER1G,PDGFRA,TBK1,MAP3K8,IRAK4 |
| VDR/RXR Activation | 1.95 | 0.0641 | PDGFA,IL1RL1,HR,THBD,KLF4 |
| Semaphorin Signaling in Neurons | 1.94 | 0.0784 | MET,RHOB,DPYSL3,PLXNB1 |
| LXR/RXR Activation | 1.91 | 0.0545 | FDFT1,IL1A,LDLR,SREBF1,IL1RL1,PTGS2 |
| Hepatic Fibrosis/Hepatic Stellate Cell Activation | 1.88 | 0.0444 | MET,IL1A,MYH9,PDGFA,IL1RL1,PDGFRA,SMAD7,COL18A1 |
| Hepatic Cholestasis | 1.78 | 0.0461 | IL1A,PRKAR2B,SREBF1,IL1RL1,MAPK8,OSM,IRAK4 |
| IL-8 Signaling | 1.75 | 0.0421 | GNAI3,MTOR,RHOB,MAPK8,PTGS2,GNA13,IRAK4,MYL12B |
| Nucleotide Excision Repair Pathway | 1.72 | 0.0909 | ERCC4,XPC,POLR2J |
Gene expression values of cholesterol related genes.
| Gene Symbol | Log2FC | |
|---|---|---|
| FDFT1 | −0.31606 | 0.00267 |
| SQLE | −0.2705 | 0.001057 |
| NSDHL | −0.2293 | 0.016672 |
| MSMO1 | −0.26965 | 0.012593 |
| SC5D | −0.27862 | 0.002411 |
| SREBF-1 | −0.16536 | 0.02396 |
| LDLR | −0.37172 | 0.001701 |
Figure 4Cholesterol biosynthesis pathway. Downregulated DEGs (red ellipse) in veal calves fed with a GP-supplemented diet (p < 0.05). FDFT-1: Farnesyl-diphosphate Farnesyltransferase; SQLE: Squalene Epoxidase; NSDHL: NAD(P)-dependent Steroid Dehydrogenase-like; SC5D: Sterol-C5-desaturase; IDI-1: Isopentenyl-Diphosphate Delta Isomerase 1.
The most activated and inhibited upstream regulators in GPO vs. CTR predicted by the Upstream Regulator Analysis in IPA.
| Upstream Regulator | Molecule Type | Predicted State | |
|---|---|---|---|
| SREBF2 | Transcription regulator | Inhibited | 0.000339911 |
| SIRT2 | Transcription regulator | Inhibited | 0.027754644 |
| SREBF1 | Transcription regulator | Inhibited | 0.0015 |
| CYP51A1 | Enzyme | Activated | 6.15 × 10−5 |
| IL1B | Cytokine | Inhibited | 1.15 × 10−5 |
| POR | Enzyme | Activated | 9.32 × 10−5 |
| TLR9 | Transmembrane receptor | Inhibited | 0.00105 |
| IL5 | Cytokine | Inhibited | 0.00315 |
Figure 5Effect of GPO-supplemented diet on plasma cholesterol levels. Each point represents a single subject and differences were analyzed using the Student’s t-test.
Figure 6Malondialdehyde (MDA) levels at 0 (0.89 ± 0.03 vs. 0.65 ± 0.04) and 7 (2.14 ± 0.14 vs. 0.99 ± 0.03) days from slaughter in meat stored at 4 °C. Data represent mean ± SD, ***: p < 0.001, two-way ANOVA (5 samples/group).